Mannel Appointed as an NRG Oncology Group Chairman

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

NRG Oncology, one of the five funded network groups within NCI’s National Clinical Trials Network said Robert Mannel will serve as one of its three group chairmen. He joins Walter Curran and Norman Wolmark as the NRG Oncology group chairmen and principal investigators of the group’s federal awards. Mannell, director of the Stephenson Cancer Center,...

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe

YOU MAY BE INTERESTED IN

I have spent over 20 years running a tumor imaging metrics core at an academic cancer center. In that time, I have watched clinical trial enrollment concentrate at a relatively small number of flagship academic institutions. Unfortunately, trials do not propagate well to the community sites where most patients prefer to receive care. The explanations usually offered for why this happens have never fully accounted for what I observed.

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login